A major clinical trial has found that the common antibiotic azithromycin does not reduce wheezing symptoms in preschool children with moderate to severe episodes, a finding that could change emergency treatment for millions of young patients. The study, published in the New England Journal of Medicine, challenges a longstanding practice of prescribing antibiotics for wheezing in this age group.
Researchers enrolled 840 children across eight U.S. emergency departments who presented with acute wheezing. Of those, 521 tested positive for at least one potentially harmful bacterium. However, more than 86 percent of the children also had a viral infection, with 72.5 percent carrying a cold virus. The trial was stopped early because azithromycin showed no benefit over a placebo in easing wheeze severity. The results suggest that viral infections, not bacterial ones, are the primary trigger for wheezing episodes in preschoolers.
The study highlights a significant gap between current practice and evidence. Approximately 25 percent of preschoolers who visit the emergency department for wheezing receive antibiotics, a figure that rises to 60 percent in moderate to severe cases. Half of those children are admitted to the hospital. The researchers believe these results will help stop ineffective antibiotic use in young children who wheeze without clear signs of pneumonia, reducing unnecessary side effects and combating antibiotic resistance.
What This Means for Patients and Doctors
For parents, the takeaway is clear: if a preschooler has wheezing but no evidence of pneumonia, antibiotics are unlikely to help. The study underscores the importance of viral testing and supportive care, such as bronchodilators and steroids, rather than automatic antibiotic prescriptions. For emergency physicians, the trial provides definitive data to guide treatment decisions and avoid medications that do not improve outcomes.
Lead researcher Dr. Kurt Denninghoff, a professor of emergency medicine, noted that the work was a decade-long collaboration between pediatric asthma experts and emergency medicine researchers. The team hopes the findings will be rapidly adopted into clinical guidelines, sparing young children from unnecessary antibiotics and their potential harms. With the study now published in one of the world’s most selective medical journals, the message is expected to reach a wide audience of clinicians and shape future care for wheezing in early childhood.